Operating profit before deduction of amortization: Edesa Biotech (EDSA)
Edesa Biotech, Inc. (EDSA) focuses on the therapy of severe inflammation and the long-term utilization of dermatology patents. Tracking EBITDA visualizes commercial cash flow, where the current figure stands at 0.00. The success of the EB05 antibody will ensure strong pricing power in intensive care units. However, business sustainability depends on binary risks and the outcomes of clinical trials for immunological inhibitors.
Edesa Biotech (EDSA) - metric breakdowns and financial figures
- stock value and consensus price forecast:
- company stock exchange capitalization indicators:
- shareholders' equity book value data:
- debt level and financial liquidity data:
Debt to Equity Ratio Edesa Biotech, Inc.|EDSA - Long-Term Debt to Capital|Current Liabilities to Capital Edesa Biotech Inc|EDSA - Company Aggregate Debts|Debts to Book Value Edesa Biotech|EDSA - Company Long-Term Debts|Company Short-Term Indebtedness Edesa Biotech|Immediate Liquidity edesabiotech.com
- earnings and multiples data:
EDSA - Company Net Income|Company Profit Forecast Edesa Biotech, Inc.|EDSA - P/E Multiple|Forward P/E Multiple edesabiotech.com|EDSA - Price/Earnings to Growth Multiple|Business Value to Operating Income Before Depreciation Edesa Biotech|EDSA - Operating profit EBITDA|Earnings per share for the last twelve months Edesa Biotech|EDSA - Net earnings per share (EPS TTM)|Year-over-year net earnings per share change for the last twelve months edesabiotech.com|EDSA - Earnings per share growth in current year|Expected net earnings per share growth next year Edesa Biotech, Inc.
Summary company analytics:Edesa Biotech, Inc.
Institutional capital assesses the attractiveness of Edesa Biotech, Inc. (EDSA) through the ability of its biotechnological developments in Canada to generate real cash flow. Tracking EBITDA allows for the measurement of net operating income before taxes and interest, which is critical for evaluating the sustainability of respiratory syndrome therapy, helping investors distinguish temporary liquidity volatility from a systemic devaluation of the asset.
Who Edesa Biotech, Inc. competes with
Operating income before deduction of amortization argenx BVBA (ARGX)|BNTX - Profit before payment of interest, taxes and amortization|Abivax S.A. (ABVX) - Operating profit before deduction of amortization|ADMA Biologics, Inc. (ADMA) - Profit before payment of interest, taxes and amortization|Operating profit before deduction of amortization Protagonist Therapeutics, Inc.|Operating profit before deduction of amortization IMVT|Operating profit EBITDA Kiniksa Corp|Profit before payment of interest, taxes and amortization Grifols, S.A. (GRFS)|adaptivebiotech.com - Operating profit before amortization|Operating profit EBITDA CLDX (Celldex Therapeutics, Inc.)|Aurinia Pharmaceuticals Inc (AUPH) - Profit before interest, taxes and amortization|BioCryst Pharmaceuticals Inc - Operating profit EBITDA|Profit before interest, taxes and amortization Vera Corp|DNTH: Operating profit EBITDA|Operating profit before amortization PHVS|ABCL (AbCellera Biologics Inc.) - Operating profit EBITDA|Profit before interest, taxes and amortization Tourmaline Bio Inc TRML|Profit before payment of interest, taxes and amortization Intrexon (PGEN)|Operating income before deduction of amortization Pharming Corp|Operating profit EBITDA NKTR (Nektar Therapeutics)|Operating profit EBITDA upstreambio.com UPB|ZBIO: Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization IMNM (Immunome Inc)|GOSS: Operating profit EBITDA|KALV (KalVista Corp) - Profit before payment of interest, taxes and amortization|SEPN (Septerna Inc) - Operating profit EBITDA|pieris.com (PVLA) - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization Savara (SVRA)|RIGL - Profit before interest, taxes and amortization|AnaptysBio Corp - Operating profit before deduction of amortization|Company profit before taxes, interest and amortization ATXS (Astria Corp)|enGene Holdings Inc. - Operating profit EBITDA|Profit before interest, taxes and amortization RAPT Therapeutics Inc.|JBIO: Operating profit EBITDA|Operating profit before deduction of amortization Aclaris Therapeutics Inc.|KYTX (Kyverna) - Operating profit EBITDA|TLSA: Income before deduction of interest, taxes and amortization|Operating profit before deduction of amortization CABA (Cabaletta Bio, Inc.)|VTYX (ventyxbio.com) - Income before deduction of interest, taxes and amortization|Operating profit EBITDA THTX (Theratechnologies)|Operating income before deduction of amortization Avalo Therapeutics, Inc. (AVTX)|ELDN - Profit before payment of interest, taxes and amortization|AGEN (Agenus, Inc) - Operating profit before amortization|CLYM: Operating profit EBITDA|Operating profit before deduction of amortization Zura Bio Ltd|Operating profit before deduction of amortization ATYR|Adagene Corp (ADAG) - Operating income before deduction of amortization|Operating profit EBITDA IMA|STTK - Profit before interest, taxes and amortization|Operating profit EBITDA EQ (Equillium)|CNTB: Operating profit before amortization|IMUX - Profit before payment of interest, taxes and amortization|Operating income before deduction of amortization Atara Biotherapeutics ATRA|IFRX: Operating profit EBITDA|X4 Pharmaceuticals, Inc (XFOR) - Operating profit EBITDA|Profit before payment of interest, taxes and amortization Adicet Bio Inc.|Celularity Corp - Profit before deduction of interest, taxes, depreciation and amortization|Operating profit EBITDA INMB|BRNS (Barinthus Biotherapeutics PLC) - Income before deduction of interest, taxes and amortization|Operating profit EBITDA KZR (Kezar Life Sciences, Inc)|Operating profit EBITDA SAB Biotherapeutics Inc SABS|AKTX - Profit before payment of interest, taxes and amortization|Income before deduction of interest, taxes and amortization ENLV (Enlivex Therapeutics)|q32bio.com (QTTB) - Profit before payment of interest, taxes and amortization|Operating profit before deduction of amortization GeoVax Labs|IBIO (iBio Corp) - Operating profit EBITDA|Operating profit EBITDA Carisma Tx|Operating profit before deduction of amortization XTLB (XTL Biopharmaceuticals)|BOLT (boltbio.com) - Income before deduction of interest, taxes and amortization|Operating profit EBITDA HCWB (HCW Biologics)|Operating income before deduction of amortization Aptevo Therapeutics, Inc. (APVO)|AIM - Profit before payment of interest, taxes and amortization|Aditxt (ADTX) - Operating profit before deduction of amortization|GRI Bio, Inc. (GRI) - Profit before payment of interest, taxes and amortization|Operating profit before deduction of amortization xortx.com|Operating profit before deduction of amortization HIND|Operating profit EBITDA Revelation Biosciences Inc|Profit before payment of interest, taxes and amortization Indaptus (INDP)|BiondVax Pharmaceuticals - Operating profit before amortization|Operating profit EBITDA CALI (CalciMedica)|Affimed NV (AFMD) - Profit before interest, taxes and amortization|Allakos Therapeutics - Operating profit EBITDA|Profit before interest, taxes and amortization HOOKIPA Pharma Inc.|IGMS: Operating profit EBITDA|Operating profit before amortization ITOS|OCEA (Ocean Biomedical, Inc.) - Operating profit EBITDA|Profit before interest, taxes and amortization tcbiopharm.com TCBP|Profit before payment of interest, taxes and amortization Third Harmonic Bio, Inc. (THRD)
